By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) 

25 Science Park, Room 561

New Haven  Connecticut  06511  U.S.A.
Phone: 203-624-5606 Fax: 203-624-5627


SEARCH JOBS



Segment
Drug Discovery





Company News
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Study Demonstrates Significant Burden Of Obesity On Patients' Recovery From Acute Bacterial Skin Infections 5/20/2015 8:10:56 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Shows That Health-Related Quality-Of-Life Is Higher In ABSSSI Patients Deemed Cured Vs Improved After End Of Treatment 4/10/2015 8:21:12 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Locks In $30 Million 2/9/2015 7:29:20 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) And Eurofarma Laboratorios Enter Into Commercialization And Distribution Agreements For Delafloxacin In Brazil 1/8/2015 1:26:28 PM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.)'s Lead Candidate Delafloxacin Yields Positive Top-Line Results In Phase 3 Study In Patients With ABSSSI 1/8/2015 7:24:24 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Demonstrates Potent In Vitro Activity Of New Antibiotic Class Against Gram Negative ESKAPE Pathogens 9/8/2014 2:44:44 PM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Demonstrate Delafloxacin's Potent And Rapid Antimicrobial Activity Against Neisseria Gonorrhoeae 9/8/2014 10:10:59 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Reports On PK Profile Of A Single Oral Dose Of Delafloxacin In Support Of U.S. Phase 3 Gonorrhea Program 9/8/2014 7:40:59 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) And Hartford Hospital Demonstrate Delafloxacin's Potent In-Vitro Activity Against Complicated Urinary Tract Infection Pathogens 9/8/2014 7:39:38 AM
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Highlighting Delafloxacin And ESKAPE Candidates In Twelve Presentations At 2014 ICAAC Meeting 9/4/2014 10:19:35 AM
123456789
//-->